Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation - 1 Jan 2008

Nishizawa Yoshiki, Koyama Hidenori

Abstract excerpt

The receptor for advanced glycation end-products (RAGE) is involved in microvascular and macrovascular complications in diabetes. The expression of RAGE is up-regulated in atherosclerotic plaques of diabetic animals, and the augmentation of atherosclerosis in diabetic mice is inhibited by the competition of RAGE. An endogenous secretory RAGE (esRAGE) was identified as a novel splice variant carrying all of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Diabetic Angiopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycation End Products, Advanced

Share to Kidney Failure, Chronic

Share to Metabolic Syndrome

Share to Microcirculation

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Source

Identifiers

PMID: 18089449
DOI: 10.1053/j.jrn.2007.10.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.PMID 18089449Read ↗

RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and DiseaseSemantic proximity Read ↗

RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.Semantic proximity Read ↗

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.Semantic proximity Read ↗

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Semantic proximity Read ↗

Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.Semantic proximity Read ↗

Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic diseaseSemantic proximity Read ↗

Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.Semantic proximity Read ↗

RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.Semantic proximity Read ↗

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injurySemantic proximity Read ↗

RAGE: The Beneficial and Deleterious Effects by Diverse Mechanisms of ActionsSemantic proximity Read ↗

Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.Semantic proximity Read ↗

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.